Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer’s disease
- 1 October 2021
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 49, 128212
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Structural modeling of GSK3β implicates the inactive (DFG-out) conformation as the target bound by TDZD analogsScientific Reports, 2020
- 2018 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2018
- Synthesis and evaluation of chromenyl barbiturates and thiobarbiturates as potential antitubercular agentsBioorganic & Medicinal Chemistry Letters, 2011
- Galantamine and behavior in Alzheimer disease: analysis of four trialsActa Neurologica Scandinavica, 2011
- 3-[Benzimidazo- and 3-[benzothiadiazoleimidazo-(1,2-c)quinazolin-5-yl]-2H-chromene-2-ones as potent antimicrobial agentsBioorganic & Medicinal Chemistry Letters, 2011
- Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidatesChemico-Biological Interactions, 2010
- Neurogenesis and Alzheimer's disease: At the crossroadsExperimental Neurology, 2010
- Kinetics of Human Serum Butyrylcholinesterase Inhibition by a Novel Experimental Alzheimer Therapeutic, Dihydrobenzodioxepine CymserineNeurochemical Research, 2007
- Forecasting the global burden of Alzheimer's diseaseAlzheimer's & Dementia, 2007
- Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase InhibitorsCurrent Medicinal Chemistry, 2000